Abstract
Approximately 10% of portal hypertension-related gastrointestinal hemorrhage occurs from lesions in the stomach. These lesions are mainly gastric varices and, less commonly, portal hypertensive gastropathy and gastric vascular ectasia. Bleeding from varices other than esophageal or gastric, termed ectopic varices, is infrequent and accounts for fewer than 5% of all portal hypertension-related bleeding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sarin SK, Lahoti D, Saxena SP, Murthi NS, Makwane UK. Revalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343–1349.
Hashizume M, Kitano S, Yamaga H, Koyanagi, Sugimachi K. Endoscopic classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343–1349.
Korula J, Chink K, Ko Y, Yamada S. Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci 1991;36:303–309.
Siringo S, McCormick PA, Mistry P, et al. Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc 1991;37:51–55.
Vlavianos P, Gimson AE, Westaby D, Williams R. Balloon tamponade in variceal bleeding: use and misuse. Br Med J 1989:298:1158.
Soderlund C, et al. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scan J Gastroenterol 1990;25:622–630.
Levacher S, Letoumelin P, Pateron D, et al. Early administration of Terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–868.
Soehendra N, Grimm H, Nam VC, Berger B. N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy 1987;19(6):221–224.
Grimm H, Maydeo A, Noar M, et al. Bleeding esophagogastric varices: is endoscopic treatment with cyanoacrylate the final answer? Gastrointest Endosc 1991;37:275.
Ogawa K, Shinya I, Shimakawa T, Wagatsuma Y, Katsube A, Kajiwara T. Endoscopic variceal ligation and sclerotherapy. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacry-late for gastric variceal bleeding. J Gastroenterol Hepatol 1999;14:245–250.
Dhiman R, Chawla Y, Taneja S, Biswas R, Sharma T, Dilawari J. Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol 2002;35:222–227.
Lo G, Lai K, Cheng J, Chen M, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001:33:1060–1064.
Sarin S, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002;97:1010–1015.
Sarin S, Govil A, Jain A, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal hemorrhage. J Hepatol 1997;26:826–832.
Trudeau W, Prindville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986;32:264–268.
Gimson AES, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 1991;13:274–278.
Chang KY, Wu CS, Chen PC. Prospective, randomized trial of hypertonic glucose water and sodium tetradecyl sulfate for gastric variceal bleeding in patients with advanced liver cirrhosis. Endoscopy 1996;28:481–486.
Shiha G, El-Sayed SS. Gastric variceal ligation: a new technique. Gastrointest Endosc 1999;49:437–441.
Tripathi D, Therapondos G, Redhead DN, Madhavan KK, Hayes PC. The role of the transjugular intra-hepatic portosystemic shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002;51:270–274.
Barange K, Peron JM, Imani K, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999;30(5):1139–1143.
Stanley A J, Jalan R, Ireland HM, Redhead DN, Bouchier IA, Hayes PC. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997;11(1):171–176.
Chau T, Patch D, Chan YW, Nagral A, Dick R, Burroughs A. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981–987.
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864–871.
Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cya-noacrylate (Histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003;98:2688–2693.
Wu C-Y, Yeh H-Z, Chen G-H. Pharmacological efficacy in gastric variceal rebleeding and survival. J Clin Gastroenterol 2002;35(2):127–132.
Greenwald B, Caldwell SH, Hespenheide E, et al. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol 2003;98:1982–1988.
Sarfeh IJ, Rypins EB, Raiszadeh M, Milne N, Conroy R, Lyons KP. Serial measurement of portal hemodynamics after partial portal decompression. Surgery 1986;100:52–57.
Rypins E, Mason R, Conroy R, Sarfeh J. Predictability and maintenance of portal flow patterns after small-diameter portacaval H-grafts in man. Surgery 1986;200:706–710.
Lee MS, Cho JY, Cheon YK, et al. Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices. Gastrointest Endosc 2002;56(l):83–88.
Yoshida T, Harada T, Shigemitsu T, Takeo Y, Miyazaki S, Okita K. Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O-ring ligation. J Gastroenterol Hepatol 1999;14:730–735.
Yoshida T, Hayashi N, Miyazaki S, et al. Endoscopic Ligation of gastric varices using a detachable snare. Endoscopy 1994;26:502–505.
de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846–852.
Migoh S, Hashizume M, Tsugawa K, Tanoue K, Sugimachi K. Mechanism and control of gastric mucosal injury and bleeding. J Gastroenterol Hepatol 2000;15:142–147.
Ohta M, Tanoue K, Tarnawski A, et al. Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology 1997;112:1920–1930.
Kawanaka H, Tomikawa M, Jones M, et al. Defective mitogen-activated protein kinase (ERK2) signalling in gastric mucosa of portal hypertensive rats: potential therapeutic implications. Hepatology 2001;34:990–999.
Lemarque D, Whittle BJR. Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors. Eur J Pharmacol 1995;277:187–194.
McCormack TT, Sims J, Eyre-Brook I, et al. Gastric lesion in portal hypertension: inflammatory gastritis or congestive gastropathy. Gut 1985;26:1226–1232.
Hashizume M, Sugimachi K. Classification of gastric lesions associated with portal hypertension. J Gastroenterol Hepatol 1995;10:339–343.
Spina GP, Arcidiacono R, Bosch J, et al. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, Sept. 19, 1992. J Hepatol 1994;21:461–467.
Satin SK. Diagnostic issues: portal hypertensive gastropathy and gastric varices. In: DeFranchis R, ed. Portal Hypertension II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Blackwell Science, Oxford, UK, 1996, pp. 30–55.
Primignani M, Materia M, Preatoni P, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. Gastroenterology 2000;l19:181–187.
Stewart C, Sanyal A. Grading portal gastropathy: validation of a gastropathy scoring system. Am J Gastroenterol 2003;98:1758–1765.
Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984;87:1165–1170.
Payen JL, Cales P, Voigt JJ, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 1995;108:138–144.
D’Amico G, Montalbano L, Traina M, et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990;99:1558–1564.
Zhou Y, Qiao L, Wu J, Hu H, Xu C. Control of bleeding in portal hypertensive gastropathy. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol 2002;17:973–979.
Panes J, Bordas J, Pique J, et al. Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology 1993;17:213–218.
Perez-Ayuso R, Pique J, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991;337:1431–1434.
Sarin SK, Shahi H, Jain M, Jain A, Issar S, Murthy N. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol 2000;95:2888–2893.
Sarin SK, Sreenivas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992;102:994–999.
Kamath PS, Lacerda M, Ahlquist D, McKusick M, Andrews J, Nagorney D. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000;118:905–911.
Tran A, Villeneuve J-P, Bilodeau M, et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol 1999;94:2909–2911.
Spahr L, Villeneuve JP, Dufresne MP. et al. Gastric antral ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999;44:739–742.
Vincent C, Pomier-Layrargues G, Dagenais M, et al. Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transplant 2002;8(8):717–720.
Perchik L, Max TC. Massive hemorrhage from varices of the duodenal loop in a cirrhotic patient. Radiology 1963;80:641–644.
Itzchak Y, Glickman MG. Duodenal varices in extrahepatic portal obstruction. Radiology 1977;124:619–624.
Weisner RII, LaRusso N, Dozois RR. Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology 1986;90:316–322.
Smith-Lang G, Scott J, Long RG, Sherlock S. Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology 1981;80:1031–1036.
Vlamonte M, Pereiras R, Russel E, LePlage J, White P, Hudson D. Transhepatic obliteration of gastroesophageal varices in acute and non-acute bleeders. Am J Roentgenol 1977;129:237–241.
Ackerman NB, Graeber GM, Fey J. Enterostomal varices secondary to portal hypertension: progression of disease in conservatively managed cases. Arch Surg 1980;115:1454–145.
Ryu R, Nemack A, Chrisman H, Saker M, Blei A. Treatment of stomal variceal hemorrhage with TIPS: case report and review of the literature. Cardiovasc Intervent Radiol 2000;23(4):301–303.
Burroughs AK, Jenkins WJ Sherlock S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983;309:1539–1542.
Lebrec D, Poynard T, Bernuau J, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984;4:355–358.
Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal re-bleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997;25:63–70.
Widrich WC, Robbins AH, Nabseth DC. Transhepatic embolization of varices. Cardiovasc Intervent Radiol 1980;3:298–307.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Stewart, C.A., Kamath, P.S. (2005). Clinical Features and Management of Gastric Varices, Portal Hypertensive Gastropathy, and Ectopic Varices. In: Sanyal, A.J., Shah, V.H. (eds) Portal Hypertension. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-59259-885-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-59259-885-4_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-386-2
Online ISBN: 978-1-59259-885-4
eBook Packages: MedicineMedicine (R0)